SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-019302
Filing Date
2020-04-28
Accepted
2020-04-28 17:22:54
Documents
4
Period of Report
2020-04-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oric-8k_20200428.htm 8-K 44767
2 EX-3.1 oric-ex31_27.htm EX-3.1 36168
3 EX-3.2 oric-ex32_67.htm EX-3.2 1095498
4 EX-99.1 oric-ex991_68.htm EX-99.1 7425
  Complete submission text file 0001564590-20-019302.txt   1185086
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 20826255
SIC: 2834 Pharmaceutical Preparations